Skip to main content
. 2016 Oct 9;8(3):5474–5486. doi: 10.18632/oncotarget.12547

Table 2. Univariate and multivariate analysis of prognostic factors for overall survival rate.

Univariate analysis Multivariate analysis
Variable HR (95%CI) P HR (95%CI) P
Age 0.994 (0.980-1.009) 0.442
Gender (male) 1.030 (0.826-1.286) 0.792
HBsAg (positive) 0.881 (0.583-1.331) 0.547
Liver cirrhosis 0.945 (0.781-1.144) 0.564
Child–Pugh B 3.081 (1.924-7.510) <0.001
ICG-R15 1.088 (1.046-1.132) <0.001 1.046 (1.002-1.092) 0.042
BCLC A 7.445 (1.844-30.139) 0.005
ALT 0.999 (0.995-1.003) 0.690
TB 1.016 (1.001-1.032) 0.039
AKP 1.001 (0.997-1.005) 0.569
GGT 1.001 (0.999-1.003) 0.336
Albumin 0.951 (0.913-0.989) 0.013
INR 5.649 (1.640-19.455) 0.006
Platelet 1.000 (0.997-1.002) 0.761
AFP 1.000 (1.000-1.000) 0.121
Tumor size 1.216 (1.138-1.299) <0.001 1.113 (1.023-1.210) 0.013
Operation time 1.001 (1.000-1.003) 0.137
Blood loss 1.000 (1.000-1.001) 0.004
Anatomical resection 0.768 (0.646-0.914) 0.003 0.767 (0.623-0.944) 0.012
Tumor differentiation
(moderate/poor)
2.427 (1.340-4.394) 0.003
Low-MVI 1.691 (1.090-2.621) 0.019
High-MVI 3.764 (2.527-5.697) <0.001 2.766 (1.675-4.566) <0.001
Transfusion (yes) 1.760 (1.211-2.558) 0.003

HBsAg, hepatitis B surface antigen; ICG-R15, indocyanine green retention rate at 15 minutes; ALT, alanine aminotransferase; TB, total bilirubin; GGT, gamma glutamyl transpeptidase; AKP, alkaline phosphatase; INR, International Normalized Ratio; AFP, alpha-fetoprotein; MVI, microvascular invasion.